NasdaqGS - Nasdaq Real Time Price • USD
Cutera, Inc. (CUTR)
At close: April 23 at 4:00 PM EDT
Earnings Estimate
| CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 3 | 3 | 3 | 3 |
| Avg. Estimate | -1 | -0.87 | -3.88 | -2.93 |
| Low Estimate | -1.09 | -0.93 | -4.76 | -3.79 |
| High Estimate | -0.88 | -0.8 | -3.05 | -2.33 |
| Year Ago EPS | -0.8 | -0.69 | -4.7 | -3.88 |
Revenue Estimate
| CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 5 | 5 | 5 | 5 |
| Avg. Estimate | 37.32M | 39.53M | 162.87M | 176.88M |
| Low Estimate | 33.9M | 38.1M | 159.94M | 166.3M |
| High Estimate | 39.92M | 41.72M | 164.28M | 183M |
| Year Ago Sales | 54.99M | 61.22M | 212.37M | 162.87M |
| Sales Growth (year/est) | -32.10% | -35.40% | -23.30% | 8.60% |
Earnings History
| CURRENCY IN USD | 3/31/2023 | 6/30/2023 | 9/30/2023 | 12/31/2023 |
|---|---|---|---|---|
| EPS Est. | -0.39 | -0.63 | -0.92 | -0.94 |
| EPS Actual | -0.8 | -0.69 | -1.61 | -1.35 |
| Difference | -0.41 | -0.06 | -0.69 | -0.41 |
| Surprise % | -105.10% | -9.50% | -75.00% | -43.60% |
EPS Trend
| CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Current Estimate | -1 | -0.87 | -3.88 | -2.93 |
| 7 Days Ago | -1 | -0.87 | -3.88 | -2.93 |
| 30 Days Ago | -0.95 | -0.9 | -3.53 | -2.53 |
| 60 Days Ago | -0.79 | -0.67 | -2.93 | -2.26 |
| 90 Days Ago | -0.8 | -0.67 | -2.93 | -2.19 |
EPS Revisions
| CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | 3 | 3 | 2 | 2 |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| CURRENCY IN USD | CUTR | Industry | Sector | S&P 500 |
|---|---|---|---|---|
| Current Qtr. | -25.00% | -- | -- | 0.40% |
| Next Qtr. | -26.10% | -- | -- | 9.90% |
| Current Year | 17.40% | -- | -- | 4.30% |
| Next Year | 24.50% | -- | -- | 13.40% |
| Next 5 Years (per annum) | 25.00% | -- | -- | 11.09% |
| Past 5 Years (per annum) | 8.83% | -- | -- | -- |
Research Analysis
Upgrades & Downgrades
| Reiterates | Stephens & Co.: Overweight to Overweight | 3/22/2024 |
| Upgrade | William Blair: Underperform to Market Perform | 3/22/2024 |
| Reiterates | Stephens & Co.: Overweight to Overweight | 3/6/2024 |
| Reiterates | Stephens & Co.: Overweight to Overweight | 12/22/2023 |
| Maintains | Piper Sandler: Neutral to Neutral | 11/9/2023 |
| Maintains | Stifel: Buy to Buy | 11/9/2023 |
Related Tickers
SINT Sintx Technologies, Inc.
0.0358
-5.79%
NUWE Nuwellis, Inc.
0.2964
-9.36%
BBLG Bone Biologics Corporation
1.6000
0.00%
DYNT Dynatronics Corporation
0.5392
+0.22%
INVO INVO Bioscience, Inc.
1.3000
+4.84%
BSGM BioSig Technologies, Inc.
1.4800
-4.82%
BIOL BIOLASE, Inc.
0.1511
+0.73%
ESTA Establishment Labs Holdings Inc.
49.69
+2.94%
VERO Venus Concept Inc.
0.7600
-6.75%
PACB Pacific Biosciences of California, Inc.
1.4700
-5.77%